About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker JNJ

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Nov 12, 2026Elizabeth Forminard
EVP, Chief Legal Officer
JNJ
Johnson & Johnson
Sale13,072$284.39$3.7M SaleForm 4 ↗
Sep 2, 2026Timothy Schmid
EVP, WW Chair, MedTech
JNJ
Johnson & Johnson
Sale22,527$274.74$6.2M SaleForm 4 ↗
Sep 2, 2026Timothy Schmid
EVP, WW Chair, MedTech
JNJ
Johnson & Johnson
Sale11,070$274.74$3.0M SaleForm 4 ↗
Aug 17, 2026Jennifer L. Taubert
EVP, WWC. Innovative Medicine
JNJ
Johnson & Johnson
Sale15,000$263.36$4.0M SaleForm 4 ↗
Aug 13, 2026Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale102,315$261.00$26.7M SaleForm 4 ↗
Aug 13, 2026Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale20,976$262.00$5.5M SaleForm 4 ↗
Aug 6, 2026Elizabeth Forminard
EVP, Chief Legal Officer
JNJ
Johnson & Johnson
Sale6,574$255.93$1.7M SaleForm 4 ↗
Aug 6, 2026Elizabeth Forminard
EVP, Chief Legal Officer
JNJ
Johnson & Johnson
Sale9,344$257.76$2.4M SaleForm 4 ↗
Aug 5, 2026Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale6,523$258.74$1.7M SaleForm 4 ↗
Aug 5, 2026Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale41,957$258.06$10.8M SaleForm 4 ↗
Jul 20, 2026Vanessa Broadhurst
EVP, Global Corp Affairs
JNJ
Johnson & Johnson
Sale23,054$251.27$5.8M SaleForm 4 ↗
Jun 11, 2026Kathryn E. Wengel
EVP, Chief TO and Risk Officer
JNJ
Johnson & Johnson
Sale10,000$241.15$2.4M SaleForm 4 ↗
Feb 27, 2026Robert J. Decker
VP Corporate Controller
JNJ
Johnson & Johnson
Sale4,075$247.87$1.0M SaleForm 4 ↗
Feb 20, 2026Timothy Schmid
EVP, WW Chair, MedTech
JNJ
Johnson & Johnson
Sale1,322$245.66$324.8K SaleForm 4 ↗
Feb 18, 2026Timothy Schmid
EVP, WW Chair, MedTech
JNJ
Johnson & Johnson
Sale8,998$244.53$2.2M SaleForm 4 ↗
Feb 18, 2026Timothy Schmid
EVP, WW Chair, MedTech
JNJ
Johnson & Johnson
Sale13,625$244.20$3.3M SaleForm 4 ↗
Feb 17, 2026James D. Swanson
EVP, CIO
JNJ
Johnson & Johnson
Sale20,521$242.70$5.0M SaleForm 4 ↗
Feb 17, 2026Joseph J. Wolk
Exec VP, CFO
JNJ
Johnson & Johnson
Sale24,961$242.68$6.1M SaleForm 4 ↗
Feb 17, 2026Joseph J. Wolk
Exec VP, CFO
JNJ
Johnson & Johnson
Sale33,386$242.75$8.1M SaleForm 4 ↗
Feb 17, 2026Joseph J. Wolk
Exec VP, CFO
JNJ
Johnson & Johnson
Sale12,066$242.87$2.9M SaleForm 4 ↗
Feb 17, 2026Joseph J. Wolk
Exec VP, CFO
JNJ
Johnson & Johnson
Sale19,241$242.99$4.7M SaleForm 4 ↗
Feb 17, 2026John C. Reed
EVP, Innovative Medicine, R&D
JNJ
Johnson & Johnson
Sale2,283$243.00$554.8K SaleForm 4 ↗
Feb 17, 2026John C. Reed
EVP, Innovative Medicine, R&D
JNJ
Johnson & Johnson
Sale29,927$243.00$7.3M SaleForm 4 ↗
Feb 17, 2026John C. Reed
EVP, Innovative Medicine, R&D
JNJ
Johnson & Johnson
Sale21,721$243.00$5.3M SaleForm 4 ↗
Feb 17, 2026Vanessa Broadhurst
EVP, Global Corp Affairs
JNJ
Johnson & Johnson
Sale6,197$243.39$1.5M SaleForm 4 ↗
Feb 13, 2026James D. Swanson
EVP, CIO
JNJ
Johnson & Johnson
Sale22,191$243.71$5.4M SaleForm 4 ↗
Feb 13, 2026James D. Swanson
EVP, CIO
JNJ
Johnson & Johnson
Sale19,368$243.76$4.7M SaleForm 4 ↗
Jan 26, 2026Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale48,782$221.48$10.8M SaleForm 4 ↗
Jan 26, 2026Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale51,218$220.99$11.3M SaleForm 4 ↗
Nov 26, 2025John G. Morikis
Director
JNJ
Johnson & Johnson
Buy1,250$206.15$257.7K BuyForm 4 ↗
Oct 17, 2025John C. Reed
EVP, Innovative Medicine, R&D
JNJ
Johnson & Johnson
Sale21,721$192.71$4.2M SaleForm 4 ↗
Sep 4, 2025Jennifer L. Taubert
EVP, WWC. Innovative Medicine
JNJ
Johnson & Johnson
Sale56,471$177.81$10.0M SaleForm 4 ↗
Aug 22, 2025Joaquin Duato
CEO and Chairman of the Board, Director
JNJ
Johnson & Johnson
Sale125,824$179.21$22.5M SaleForm 4 ↗
Aug 15, 2025Joseph J. Wolk
Exec VP, CFO
JNJ
Johnson & Johnson
Sale16,820$176.91$3.0M SaleForm 4 ↗
Jul 17, 2025John C. Reed
EVP, Innovative Medicine, R&D
JNJ
Johnson & Johnson
Sale19,137$163.55$3.1M SaleForm 4 ↗
Feb 25, 2025Robert J. Decker
VP Corporate Controller
JNJ
Johnson & Johnson
Sale6,999$165.88$1.2M SaleForm 4 ↗
Feb 18, 2025Timothy Schmid
EVP, WW Chair, MedTech
JNJ
Johnson & Johnson
Sale403$156.15$62.9K SaleForm 4 ↗
Feb 7, 2025Joseph J. Wolk
Exec VP, CFO
JNJ
Johnson & Johnson
Sale13,015$153.89$2.0M SaleForm 4 ↗
Dec 12, 2024Mark A. Weinberger
Director
JNJ
Johnson & Johnson
Buy1,000$147.22$147.2K BuyForm 4 ↗
Apr 30, 2024Eugene A. Woods
Director
JNJ
Johnson & Johnson
Buy100$145.53$14.6K BuyForm 4 ↗

40 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:02 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances